Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers
SUMMARY
Novo Nordisk, the company behind Ozempic, criticized President Biden and Senator Bernie Sanders after they accused it of overcharging US consumers for prescription drugs. In a USA Today op-ed, Biden and Sanders highlighted the high prices Americans pay for drugs like Ozempic compared to other countries, citing a KFF report showing Ozempic costs $936 in the US versus $83 in France. Novo Nordisk rebutted, arguing that price comparisons ignore different healthcare systems and that most insured Americans pay $25 or less per month. The demand for weight-loss drugs like Ozempic has surged recently, causing a correlated market impact.
